ANDA 77713, held by Tp Anda Holdings. Sertraline Hydrochloride.
As of Nov 16, 2026, ANDA 77713 (Sertraline Hydrochloride), held by Tp Anda Holdings, was first approved by FDA on Feb 6, 2007, with 5 approved supplements and 0 published complete response letters.
Sertraline hydrochloride tablets are indicated for the treatment of the following: Major depressive disorder (MDD) Obsessive-compulsive disorder (OCD) Panic disorder (PD) Posttraumatic stress disorder (PTSD) Social anxiety disorder (SAD) Premenstrual dysphoric disorder (PMDD) Sertraline hydrochloride tablets are a selective serotonin reuptake inhibitor (SSRI) indicated for the treatment of: Major depressive disorder (MDD) Obsessive-compulsive disorder (OCD) Panic disorder (PD) Posttraumatic stress disorder (PTSD) Social anxiety disorder (SAD) Premenstrual dysphoric disorder (PMDD)
| Date | Submission | Status | Documents |
|---|---|---|---|
| Feb 6, 2007 | Original application | Approved | None posted |
| Sertraline HydrochlorideEQ 25MG BASE · tablet;oral | Sertraline Hydrochloride | Discontinued |
| Sertraline HydrochlorideEQ 50MG BASE · tablet;oral | Sertraline Hydrochloride | Discontinued |
| Sertraline HydrochlorideEQ 100MG BASE · tablet;oral | Sertraline Hydrochloride | Discontinued |
| Sertraline HydrochlorideEQ 150MG BASE · tablet;oral | Sertraline Hydrochloride | Rx |
| Sertraline HydrochlorideEQ 200MG BASE · tablet;oral | Sertraline Hydrochloride | Rx |
| Feb 21, 2020 | Supplement 6Labeling · Standard review | Approved | None posted |
| Oct 2, 2015 | Supplement 4Labeling | Approved | None posted |
| Oct 2, 2015 | Supplement 5Labeling · Standard review | Approved | None posted |
| Dec 7, 2007 | Supplement 1Labeling | Approved | None posted |
| Dec 7, 2007 | Supplement 3Labeling | Approved | None posted |
| Feb 6, 2007 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters